8-KItem 7.01 · Reg FD Disclosure
Elevance Health ($ELV) reaffirms FY2026 adjusted shareholders’ earnings ≥ $25.50/share and 2026 benefit…
Filed with the SEC on · Summarized by InvestorsBot
Elevance Health ($ELV) reaffirms FY2026 adjusted shareholders’ earnings ≥ $25.50/share and 2026 benefit expense ratio 90.2% ±50 bps; officers to speak with investors next week. 📈🗓️ #Guidance #Healthcare
CMS notified Elevance on Feb 27 of intent to impose intermediate sanctions (suspend MA‑PD enrollments & certain beneficiary communications) effective Mar 31, 2026 unless resolved. Guidance assumes possible impact; company cannot reconcile adjusted EPS to GAAP due to uncertain potential payments. ⚖️🚫 $ELV #CMS #Medicare